PTHLH and neoplasm: The possible mechanistic importance of tumoral PTHrP secretion in promoting tumor-associated osteolysis and, in turn, osteolytic BMET progression, has already been established in one commonly studied pre-clinical ER− human BMET model, where osteolytic BMET progression does not occur in the absence of tumoral PTHrP bioactivity[8,42].